Pharmaceutical Industry Information Portal

HomeTagsAntibodies

All posts by tag

Antibodies

Sanofi and Blackstone collaborate on 300 million euros to develop innovative treatment for multiple myeloma

Sanofi and Blackstone today announced a strategic, risk-sharing collaboration under which funds managed by Blackstone Life Sciences (BXLS) will contribute up to €300 million...

U.S. FDA approves medicine for the treatment of relapsed or refractory multiple myeloma

The Janssen Pharmaceutical Companies of Johnson & Johnson and its China-focused partner Legend Biotech Corp. developed a therapy to treat a type of white blood...

COVID certificates on basis of positive tests for antibodies In Russia, from February 21

In Public Services, it is now possible to issue a COVID certificate based on the results of an antibody test. The corresponding order of...

FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant

The following is attributed to Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research. As we have throughout the COVID-19 pandemic,...

Gamaleya Center starts testing its anti-COVID medicine based on monoclonal antibodies

Russia’s Gamaleya National Research Center for Epidemiology and Microbiology is launching trials of its new anti-COVID medicine based on monoclonal antibodies, the center’s chief...

The combination of AstraZeneca and Sputnik Light vaccines in Azerbaijan shows strong neutralizing antibodies growth

R-Pharm Group, the Russian Direct Investment Fund (RDIF) and AstraZeneca announce preliminary virus neutralizing activity results of combined use of the AstraZeneca vaccine (developed...
spot_img

Expert Articles

spot_img